BREAKING: White House to launch ‘TrumpRx’ website, lowering drug costs for Americans

The website will be designed to allow people to pay cash for certain prescriptions directly from the government website instead of from private companies, at a discounted price negotiated by the government.

Trump, as well as the CEO of Pfizer, Albert Bourla, are set to announce the details later on Tuesday, the outlet reported. Pfizer is also set to invest $70 billion into manufacturing in the United States.

“It’s a win for American patients, a win for American leadership, and it’s a win for Pfizer because it provides the certainty and stability we need to continue advancing new breakthrough medicines for patients,” Pfizer spokesman Amy Rose said.

White House spokesman Kush Desai added, “President Trump is leveraging the power of the federal government to drastically cut drug prices for everyday Americans. Democrats talked the talk for decades about drug prices, but only President Trump is actually walking the walk.”

Last week, Trump announced that drug companies would face 100 percent tariffs if they were not building manufacturing facilities in the United States. However, with the move from Pfizer, they will likely be able to avoid the tariffs. He has also repeatedly called on drug companies to use direct-to-consumer drug platforms as well as offering "most favored nation" pricing, meaning that drugs prices in the US would be comparable to those in other developed nations that use products from US-based drug companies.